Literature DB >> 21459758

Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.

Meilin Wang1, Haiyan Chu, Fu Yan, Chao Qin, Pu Li, Lin Yuan, Changjun Yin, Jianfeng Xu, Zhengdong Zhang.   

Abstract

A recent genome-wide association study identified a common variant (rs798766) on 4p16.3 that confers susceptibility to bladder cancer. The aim of this study was to assess whether rs798766 is associated with risk of bladder cancer in a Chinese population as well. We genotyped this variant using TaqMan technology in a case-control study of 815 histologically confirmed bladder cancer patients and 1141 controls. Normal bladder tissues adjacent to tumors were used to evaluate the functionality of rs798766 using quantitative real-time reverse transcription-polymerase chain reaction. We found that rs798766 CT/TT genotypes were associated with a significantly increased risk of bladder cancer (odds ratio = 1.36, 95% confidence interval = 1.10-1.67), compared with the CC genotype. Furthermore, rs798766 was significantly associated with FGFR3 messenger RNA expression. However, no significant interaction between rs798766 and tobacco smoking on bladder cancer risk was observed (P(multiplicative) = 0.785). Our results suggest that rs798766 on 4p16.3 may contribute to bladder cancer susceptibility in a Chinese population and explains an additional 3.65% of population attributable risk for bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459758      PMCID: PMC3314283          DOI: 10.1093/carcin/bgr060

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

1.  Bladder Cancer Working Group report.

Authors:  Yoshiyuki Kakehi; Yoshihiko Hirao; Wun-Jae Kim; Seiichiro Ozono; Naoya Masumori; Naoto Miyanaga; Yasutomo Nasu; Akira Yokomizo
Journal:  Jpn J Clin Oncol       Date:  2010-09       Impact factor: 3.019

2.  A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer.

Authors:  M Wang; M Wang; L Yuan; D Wu; Z Zhang; C Yin; G Fu; Q Wei; Z Zhang
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

3.  A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

Authors:  Lambertus A Kiemeney; Patrick Sulem; Soren Besenbacher; Sita H Vermeulen; Asgeir Sigurdsson; Gudmar Thorleifsson; Daniel F Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Carlo Zanon; Jelena Kostic; Gisli Masson; Hjordis Bjarnason; Stefan T Palsson; Oskar B Skarphedinsson; Sigurjon A Gudjonsson; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; D Timothy Bishop; Sei Chung Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Carolyn D Hurst; Petra J de Verdier; Charlotta Ryk; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Marcello Campagna; Donatella Placidi; Cecilia Arici; Maurice P Zeegers; Eliane Kellen; Berta Saez Gutierrez; José I Sanz-Velez; Manuel Sanchez-Zalabardo; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Meinolf Blaszkewicz; Holger Dietrich; Roel A Ophoff; Leonard H van den Berg; Kristin Alexiusdottir; Kristleifur Kristjansson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; Augustine Kong; Thorgeir Thorgeirsson; N Aydin Mungan; Annika Lindblom; Michael A van Es; Stefano Porru; Frank Buntinx; Klaus Golka; José I Mayordomo; Rajiv Kumar; Giuseppe Matullo; Gunnar Steineck; Anne E Kiltie; Katja K H Aben; Eirikur Jonsson; Unnur Thorsteinsdottir; Margaret A Knowles; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2010-03-28       Impact factor: 38.330

Review 4.  Epidemiology and etiology of premalignant and malignant urothelial changes.

Authors:  S M Cohen; T Shirai; G Steineck
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

5.  Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.

Authors:  Tahlita C M Zuiverloon; Madelon N M van der Aa; Theo H van der Kwast; Ewout W Steyerberg; Hester F Lingsma; Chris H Bangma; Ellen C Zwarthoff
Journal:  Clin Cancer Res       Date:  2010-04-19       Impact factor: 12.531

6.  Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population.

Authors:  Shizhi Wang; Jialin Tang; Meilin Wang; Lin Yuan; Zhengdong Zhang
Journal:  Carcinogenesis       Date:  2010-01-18       Impact factor: 4.944

7.  Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.

Authors:  Bas W G van Rhijn; André N Vis; Theo H van der Kwast; Wim J Kirkels; François Radvanyi; Engelbert C M Ooms; Dominique K Chopin; Egbert R Boevé; Adriaan C Jöbsis; Ellen C Zwarthoff
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

8.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.

Authors:  Lambertus A Kiemeney; Steinunn Thorlacius; Patrick Sulem; Frank Geller; Katja K H Aben; Simon N Stacey; Julius Gudmundsson; Margret Jakobsdottir; Jon T Bergthorsson; Asgeir Sigurdsson; Thorarinn Blondal; J Alfred Witjes; Sita H Vermeulen; Christina A Hulsbergen-van de Kaa; Dorine W Swinkels; Martine Ploeg; Erik B Cornel; Henk Vergunst; Thorgeir E Thorgeirsson; Daniel Gudbjartsson; Sigurjon A Gudjonsson; Gudmar Thorleifsson; Kari T Kristinsson; Magali Mouy; Steinunn Snorradottir; Donatella Placidi; Marcello Campagna; Cecilia Arici; Kvetoslava Koppova; Eugene Gurzau; Peter Rudnai; Eliane Kellen; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Manuel Sanchez; Berta Saez; Gabriel Valdivia; Charlotta Ryk; Petra de Verdier; Annika Lindblom; Klaus Golka; D Timothy Bishop; Margaret A Knowles; Sigfus Nikulasson; Vigdis Petursdottir; Eirikur Jonsson; Gudmundur Geirsson; Baldvin Kristjansson; Jose I Mayordomo; Gunnar Steineck; Stefano Porru; Frank Buntinx; Maurice P Zeegers; Tony Fletcher; Rajiv Kumar; Giuseppe Matullo; Paolo Vineis; Anne E Kiltie; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

9.  Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.

Authors:  Xifeng Wu; Yuanqing Ye; Lambertus A Kiemeney; Patrick Sulem; Thorunn Rafnar; Giuseppe Matullo; Daniela Seminara; Teruhiko Yoshida; Norihisa Saeki; Angeline S Andrew; Colin P Dinney; Bogdan Czerniak; Zuo-feng Zhang; Anne E Kiltie; D Timothy Bishop; Paolo Vineis; Stefano Porru; Frank Buntinx; Eliane Kellen; Maurice P Zeegers; Rajiv Kumar; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Jose Ignacio Mayordomo; Manuel Sanchez; Berta Saez; Annika Lindblom; Petra de Verdier; Gunnar Steineck; Gordon B Mills; Alan Schned; Simonetta Guarrera; Silvia Polidoro; Shen-Chih Chang; Jie Lin; David W Chang; Katherine S Hale; Tadeusz Majewski; H Barton Grossman; Steinunn Thorlacius; Unnur Thorsteinsdottir; Katja K H Aben; J Alfred Witjes; Kari Stefansson; Christopher I Amos; Margaret R Karagas; Jian Gu
Journal:  Nat Genet       Date:  2009-08-02       Impact factor: 38.330

10.  Genomewide association studies and human disease.

Authors:  John Hardy; Andrew Singleton
Journal:  N Engl J Med       Date:  2009-04-15       Impact factor: 91.245

View more
  10 in total

1.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Authors:  Thorunn Rafnar; Sita H Vermeulen; Patrick Sulem; Gudmar Thorleifsson; Katja K Aben; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; Christina A Hulsbergen-van de Kaa; Soren Besenbacher; Daniel Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Hrefna Johannsdottir; Hjordis Bjarnason; Carlo Zanon; Hafdis Helgadottir; Jon Gunnlaugur Jonasson; Laufey Tryggvadottir; Eirikur Jonsson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; D Timothy Bishop; Sei Chung-Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Margaret A Knowles; Petra J de Verdier; Charlotta Ryk; Annika Lindblom; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Angeles Panadero; José I Sanz-Velez; Manuel Sanchez; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Silvia Selinski; Holger Gerullis; Daniel Ovsiannikov; Abdolaziz Khezri; Alireza Aminsharifi; Mahyar Malekzadeh; Leonard H van den Berg; Roel A Ophoff; Jan H Veldink; Maurice P Zeegers; Eliane Kellen; Jacopo Fostinelli; Daniele Andreoli; Cecilia Arici; Stefano Porru; Frank Buntinx; Abbas Ghaderi; Klaus Golka; José I Mayordomo; Giuseppe Matullo; Rajiv Kumar; Gunnar Steineck; Anne E Kiltie; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson; Lambertus A Kiemeney
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

2.  TACC3 is essential for EGF-mediated EMT in cervical cancer.

Authors:  Geun-Hyoung Ha; Jung-Lye Kim; Eun-Kyoung Breuer; Eun-Kyoung Yim Breuer
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

3.  MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.

Authors:  Gan Yu; Weimin Yao; Wei Xiao; Heng Li; Hua Xu; Bin Lang
Journal:  J Exp Clin Cancer Res       Date:  2014-12-31

4.  Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population.

Authors:  Yu Zhang; Yan Sun; Tao Chen; Hailong Hu; Wanqin Xie; Zhihui Qiao; Na Ding; Linguo Xie; Sheng Li; Wenlong Wang; Chen Xing; Yihan Wang; Yunkai Qie; Changli Wu
Journal:  Int J Mol Sci       Date:  2014-10-24       Impact factor: 5.923

5.  C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.

Authors:  Mingkun Chen; Yunlin Ye; Baojia Zou; Suping Guo; Fangjian Zhou; Keshi Lu; Jianye Liu; Zhenzhou Xu; Hui Han; Zhuowei Liu; Yonghong Li; Kai Yao; Cundong Liu; Zike Qin
Journal:  J Transl Med       Date:  2016-02-23       Impact factor: 5.531

6.  The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City.

Authors:  Chiang-Ting Wang; Tsung-Ming Chen; Chien-Tai Mei; Chun-Feng Chang; Li-Lian Liu; Kuo-Hsun Chiu; Tsung-Meng Wu; Yu-Ching Lan; Wen-Sheng Liu; Ya-Huey Chen; Yi-Mei Joy Lin
Journal:  Biomed Res Int       Date:  2016-12-07       Impact factor: 3.411

Review 7.  Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence.

Authors:  Xiang-Yu Meng; Ming-Jun Shi; Jia-Feng Chen; Yi Liao; Bang-Wang Hu; Ahmed Hireche
Journal:  Dis Markers       Date:  2017-06-05       Impact factor: 3.434

8.  Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.

Authors:  Chenyang Xu; Xiaoling Lin; Wei Qian; Rong Na; Hongjie Yu; Haifei Jia; Haowen Jiang; Zujun Fang; S Lilly Zheng; Qiang Ding; Yishuo Wu; Jie Zheng; Jianfeng Xu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

9.  Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer.

Authors:  Qin Huo; Siqi Chen; Zhenwei Li; Juan Wang; Jiaying Li; Ni Xie
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

10.  High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.

Authors:  Zhi-Liang Huang; Zhi-Rui Lin; Yi-Ren Xiao; Xun Cao; Lin-Chun Zhu; Mu-Sheng Zeng; Qian Zhong; Zhe-Sheng Wen
Journal:  Oncotarget       Date:  2015-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.